With new hopes for German pricing, Novo Nordisk decides to roll out Tresiba there

Save

Novo Nordisk has decided to play ball in Germany. The Danish drugmaker now plans to launch its brand-new diabetes drug Tresiba in that country, despite a notorious pricing policy that Novo feared would interfere with its success.